Bead Block® and/or all indications may not be available in your territory.
Bead Block is a trademark of Biocompatibles UK Ltd and Bead Block is a registered trademark in China, EU and US.
Federal (USA) law restricts the sale of this device by or on order of a physician.
Bead Block® is manufactured by Biocompatibles UK Ltd, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey, GU9 8QL, UK. Biocompatibles, Inc. and Biocompatibles UK Ltd are BTG International group companies. BTG and the BTG roundel logo are registered trademarks of BTG International Ltd. Bead Block is a registered trademark of Biocompatibles UK Ltd.
Please enter your details to download this document.
Bead Block® is an embolic agent intended for the purpose of embolizing the blood vessels of a variety of hypervascularized tumors and arteriovenous malformations.
Bead Block® is a preformed, deformable embolic agent consisting of a biocompatible, hydrogel acrylamido polyvinyl alcohol macromer.
Bead Block® is a compressible embolic agent used in embolization therapy. This is a minimally invasive (non-surgical) procedure performed by an interventional radiologist. By blocking the blood supply to the target area, the tumor or malformation is starved of nutrients and shrinks in size.
Bead Block® embolic agent offers:
Embolization of hypervascular renal tumors in combination therapy
Bead Block® embolic agent offers the benefits associated with targeted occlusion of renal vessels and is ideally suited for super-selective arterial embolization. Recent studies* have demonstrated that super selective embolization of renal tumors prior to resection or ablation may offer the following benefits:
* Recent Studies: